John C. Meyer, MD, in conjunction with Refocus Group, is currently conducting clinical research studies to determine if the Scleral Spacing Procedure (SSP) and the PresVIEW Scleral Implant will eliminate the need for corrective eyewear arising from Presbyopia.
What is Presbyopia?
Presbyopia (which literally means “aging eye”) is an age-related eye condition that makes it more difficult to see up close, such as when you are reading. Like gray hair and wrinkles, presbyopia is a symptom caused by the natural course of aging, not a disease. The first signs of presbyopia are usually noticed between the ages of 40 and 50, and can include:
- difficulty focusing on fine print and/or small objects (particularly in low light);
- the need to hold reading materials further away in order to focus;
- eyestrain when reading for long periods; and/or,
- momentary blurred vision when transitioning between viewing distances.
Presbyopia differs from myopia (nearsightedness), hyperopia (farsightedness) and astigmatism, which are related to the shape of the eyeball and are caused by genetic and environmental factors. Unlike these commonly known eye disorders, presbyopia is simply a symptom of aging and eventually affects every individual.
Dr Meyer can diagnose presbyopia as part of a comprehensive eye examination. In addition to checking for other eye problems, he will determine your degree of presbyopia by using a standard vision test, and discuss treatment options.
About the Scleral Spacing Procedure (SSP)
The Scleral Spacing Procedure (SSP) is a minimally invasive outpatient procedure which typically takes 20 to 30 minutes per eye. Prior to surgery, you will be given numbing and anti-anxiety medication. These medications will keep you comfortable and relaxed during the procedure, and cause you to have no memory of the surgery. After the procedure, you can expect your eye to be somewhat red and sore. Although the soreness and inflammation usually go away in a few days, complete healing typically takes three to four weeks.
About the PresVIEW Scleral Implants (PSI)
PresVIEW Scleral Implants (PSI) are precision molded from ophthalmic PMMA polymer, a material which has been safely implanted in human eyes for various surgical procedures for over fifty years. Its small size and transparency allow it to be cosmetically and physically unobtrusive for the patient.
Am I A Candidate?
You may be a candidate for the SSP procedure clinical trials for presbyopia if you meet the following criteria:
- You are between the ages of 50 and 60 years old
- You have difficulty focusing on close objects
- You do not need glasses or contacts to see objects that are far away
- You have not had prior eye surgery
- You have not been diagnosed with any major medical conditions
- You live within one hour of the main office of The Eye Care Institute.
Note: SSP studies are only available to patients who meet the selected criteria as defined by Refocus Group and approved by the US Food and Drug Administration (FDA).
How Do I Join The Study?
If you think you may be a candidate and are interested in being considered for inclusion in the study, please contact The Eye Care Institute at 502-589-1500.